Valneva SE (VALN) Interest Coverage Ratio (2021 - 2026)
Valneva SE (VALN) posted quarterly Interest Coverage Ratio of 4.65 for Q1 2026, up 366.84% year-on-year from 1.0 in Q1 2025, and up 507.18% on a QoQ basis from 1.14 in Q4 2025.
Valneva SE (VALN) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Interest Coverage Ratio for 6 consecutive years, with 4.65 the latest figure, recorded in Q1 2026.
- Quarterly Interest Coverage Ratio rose 366.84% year-over-year to 4.65 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.39 (up 6.16% YoY) and the FY2025 annual result came in at 1.96, down 452.61% from the prior year.
- Interest Coverage Ratio climbed to 4.65 in Q1 2026 per VALN's latest filing, from 1.14 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for VALN reached as high as 37.92 in Q2 2022 and fell as low as 17.96 in Q3 2022.
- A 5-year average of 0.32 and a median of 1.14 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio plunged 397.68% — and 2026, when it surged 366.84%.
- Year by year, Interest Coverage Ratio stood at 1.74 in 2022, then soared by 59.94% to 0.7 in 2023, then plunged by 376.5% to 3.31 in 2024, then surged by 65.52% to 1.14 in 2025, then soared by 507.18% to 4.65 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 4.65, 1.14, and 6.49 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | 4.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.65 |
| Dec 31, 2025 | -1.14 |
| Sep 30, 2025 | -6.49 |
| Jun 30, 2025 | -0.66 |
| Mar 31, 2025 | 1.00 |
| Dec 31, 2024 | -3.31 |
| Sep 30, 2024 | -2.18 |
| Jun 30, 2024 | -1.21 |
| Mar 31, 2024 | -9.68 |
| Dec 31, 2023 | -0.70 |
| Sep 30, 2023 | 1.04 |
| Jun 30, 2023 | -1.32 |
| Mar 31, 2023 | 3.25 |
| Dec 31, 2022 | -1.74 |
| Sep 30, 2022 | -17.96 |
| Jun 30, 2022 | 37.92 |
| Mar 31, 2022 | 3.90 |
| Dec 31, 2021 | 7.44 |
| Sep 30, 2021 | -89.23 |
| Jun 30, 2021 | 14.39 |